Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
Abstract
To investigate the relationship between Krebs von den Lungen 6 (KL‐6) and CCL18 levels and the severity and progression of systemic sclerosis (SSc)–related interstitial lung disease (ILD).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 01, 2019
- Source ID
- 10.1002/art.41020
Entities
People
- Daniel E. Furst
- Dinesh Khanna
- Donald P. Tashkin
- Elizabeth R Volkmann
- Faye N. Hant
- Galina S. Bogatkevich
- Grace Kim
- Jonathan Goldin
- Julio Charles
- Masataka Kuwana
- Michael D. Roth
- Ning Li
- Philip J. Clements
- Richard Silver
- Robert M. Elashoff
- Shervin Assassi
- Tanjina Akter
Organizations
- American College of Rheumatology Research and Education Foundation
- Medical University of South Carolina
- National Heart, Lung, and Blood Institute
- Nippon Medical School
- Scleroderma Foundation
- UCLA David Geffen School of Medicine
- United States Department of Defense
- University of California, Los Angeles
- University of Michigan
- University of Texas at Austin